Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E-PRF and H-PRF in Impacted Mandibular Third Molar Surgery
NCT05772975Phase 3Completed
- Start
- May 2021
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (3 arms). Primary endpoints: Soft Tissue Healing at 7 days and Bone Regeneration at 3 months. Started May 2021; status: completed.
Beyond the preview
Go deeper on NCT05772975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05772975.